1. A combination system, comprising:
a first signal-receiving part for receiving an analog broadcast signal;
a second signal-receiving part for receiving a digital broadcast signal;
a controller for establishing signal paths in order that any of the analog and digital broadcast signals from the first and second signal-receiving parts according to an externally applied control signal may be transferred to a display device, and the other broadcast signal may be recorded on a storage medium; and
a video signal switching part for selectively providing the output signals of the first signal-receiving part and the second signal-receiving part to the display device and the storage medium, respectively, based on the signal paths established by the controller.
2. The combination system as claimed in claim 1, further comprising an optical medium reproduction device for reproducing optical media.
3. The combination system as claimed in claim 2, wherein the controller establishes the signal paths to enable any output signal of the first signal-receiving part, second signal-receiving part, and optical medium reproduction device to be recorded on the storage medium, and to enable the other output signal to be applied to the display device.
4. The combination system as claimed in claim 1, wherein the first signal-receiving part has a video cassette recorder (VCR) function capable of reproducing and recording onto a video tape.
5. The combination system as claimed in claim 1, wherein the second signal-receiving part comprises:
a moving picture experts group (MPEG) decoder for MPEG-decoding the digital broadcast signal; and
a digitalanalog converter for analogdigital-converting an output signal of the MPEG decoder.
6. The combination system as claimed in claim 1, wherein the storage medium is a video tape.
7. The combination system as claimed in claim 1, wherein the control signal is generated by any of a remote controller and an operation key provided on the combination system.
8. A combination system, comprising:
first and second signal-reproducing units for reproducing different video signal sources;
a display device for reproducing video signals output from the first and second signal-reproducing units;
a storage medium for recording any of the video signals output from the first and second signal-reproducing units; and
a switching unit for sending to the display device one of the video signals respectively output from the first and second signal-reproducing units, and for sending another video signal to the storage medium, in response to an external control signal.
9. The combination system as claimed in claim 8, wherein the first signal-reproducing unit establishes a signal path of the switching unit.
10. The combination system as claimed in claim 9, wherein the second signal-reproducing unit sends an output signal to one of the display device and the storage medium along the signal path established by the first signal-reproducing unit.
11. The combination system as claimed in claim 8, wherein the control signal is applied to the first signal-reproducing unit.
12. The combination system as claimed in claim 8, wherein the first signal-reproducing unit has a video cassette recorder (VCR) function capable of reproducing and recording onto a video tape.
13. The combination system as claimed in claim 8, wherein the second signal-reproducing unit is at least one of a digital broadcast signal-receiving device and an optical recordingreproducing device.
14. The combination system as claimed in claim 13, wherein, if the second signal-reproducing unit is a plurality of digital devices, the plurality of digital devices are each connected to any of the display devices and the storage medium through a signal path established by the first signal-reproducing unit.
15. The combination system as claimed in claim 8, wherein the storage medium is a video tape.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A compound of formula (I):
wherein:
R1 is (C1-C6)alkoxy or NRaRb;
R2 is cyano, (C1-C6)alkoxycarbonyl or \u2014C(O)NReRf;
R3 is halo, cyano, (C1-C6)alkyl, cycloalkyl, aryl, heteroaryl, aryl(C1-C6)alkyl or (C1-C6)alkoxycarbonyl;
each of R6, R7 and R8 is independently hydrogen, halo, cyano, (C1-C6)alkyl, cycloalkyl, aryl, heteroaryl, aryl(C1-C6)alkyl or (C1-C6)alkoxycarbonyl;
Rc and Rd are independently hydrogen, (C1-C6)alkyl, (C1-C6)alkanoyl or arylcarbonyl; or Rc and Rd taken together with the nitrogen to which they are attached form a pyrrolidino, piperidino, piperazino, or morpholino ring;
Re and Rf are independently hydrogen or (C1-C6)alkyl; or Rc and Rd taken together with the nitrogen to which they are attached form a pyrrolidino, piperidino, piperazino, or morpholino ring;
R4 and R5 are each hydrogen; or R4 is (C1-C6)alkyl and R5 is cyano;
Ra and Rb are independently hydrogen or (C1-C6)alkyl; or Ra and Rb taken together with the nitrogen to which they are attached form a pyrrolidino, piperidino, piperazino, or morpholino ring;
wherein any aryl or heteroaryl of R3, R6, R7 or R8 is optionally substituted with one or more groups independently selected from halo, hydroxy, cyano, CF3, OCF3, OCHF2, (C1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkanoyl, aryloxy, NRgRh, benzyloxy, (C1-C6)alkoxycarbonyl, and (C1-C6)alkanoyloxy; and
each Rg and Rh is independently hydrogen or (C1-C6)alkyl; or Rg and Rh taken together with the nitrogen to which they are attached form a pyrrolidino, piperidino, piperazino, or morpholino ring;
or a salt thereof.
2. A compound of formula (II):
wherein:
R1 is (C1-C6)alkoxy or NRaRb;
R2 is cyano, or (C1-C6)alkoxycarbonyl;
R3 is halo, (C1-C6)alkyl, aryl, aryl(C1-C6)alkyl, cyano, or (C1-C6)alkoxycarbonyl;
R4 and R5 are each hydrogen; or R4 is (C1-C6)alkyl and R5 is cyano; and
each Ra and Rb is independently hydrogen or (C1-C6)alkyl; or Ra and Rb taken together with the nitrogen to which they are attached form a pyrrolidino, piperidino, piperazino, or morpholino ring;
wherein any aryl of R3 is optionally substituted with one or more groups independently selected from halo, hydroxy, (C1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkoxycarbonyl, and (C1-C6)alkanoyloxy;
or a salt thereof.
3. The compound of claim 1 wherein the compound of formula (I) is a compound of formula (III):
wherein:
R1 is (C1-C6)alkoxy or NRaRb;
R2 is cyano, or (C1-C6)alkoxycarbonyl;
R3 is halo, (C1-C6)alkyl, aryl, aryl(C1-C6)alkyl, cyano, or (C1-C6)alkoxycarbonyl;
R4 and R5 are each hydrogen; or R4 is (C1-C6)alkyl and R5 is cyano; and
each Ra and Rb is independently hydrogen or (C1-C6)alkyl; or Ra and Rb taken together with the nitrogen to which they are attached form a pyrrolidino, piperidino, piperazino, or morpholino ring;
wherein any aryl of R3 is optionally substituted with one or more groups independently selected from halo, hydroxy, (C1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkoxycarbonyl, and (C1-C6)alkanoyloxy;
or a salt thereof.
4. The compound of claim 1 wherein R1 is NRaRb.
5. The compound of claim 1 wherein R1 is ethoxy or isopropoxy.
6. The compound of claim 1 wherein R1 is piperidino.
7. The compound of claim 1 wherein R1 is morpholino, piperazino or diethylamino.
8. The compound of claim 1 wherein R2 is ethoxycarbonyl, isopropoxycarbonyl, or cyano.
9. The compound of claim 1 wherein R3 is aryl, which is optionally substituted with one or more groups independently selected from halo, hydroxy, cyano, CF3, OCF3, OCHF2, (C1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkanoyl, aryloxy, NRgRh, benzyloxy, (C1-C6)alkoxycarbonyl, and (C1-C6)alkanoyloxy.
10. The compound of claim 1 wherein R3 is bromo, n-propyl, 4-t-butylphenyl, phenyl, 3,5-dimethoxyphenyl, 3,5-dihydroxyphenyl, 3-hydroxy-5-methoxyphenyl, 3,4,5-trimethoxyphenyl, 2,4,6-trimethoxyphenyl, 1,2,3-trimethoxyphenyl, indol-5-yl, benzoxazol-5-yl, benzofuran-5-yl, indazol-5-yl, 3,4-methylenedioxyphenyl, quinolin-5-yl, 4-methoxy-3-trifluoromethylphenyl, 4-trifluoromethylphenyl, 4-cyanophenyl, 3-benzyloxy-4-trifluoromethylphenyl, 4-(diethylamino)phenyl, 3,5-dichlorophenyl, 4-phenoxyphenyl, naphthyl, 4-acetylphenyl or 4-isopropyl-2-methoxyphenyl.
11. The compound of claim 1 wherein R3 is phenyl, which is optionally substituted with one or more (C1-C6)alkyl groups.
12. The compound of claim 1 wherein R3 is bromo, propyl, phenyl, 4-tert-butylphenyl, 3-methoxy,5-hydroxyphenyl, 3,5-dihydroxyphenyl, or 3,5-dimethoxyphenyl.
13. The compound of claim 1 wherein R4 and R5 are each hydrogen.
14. The compound of claim 1 wherein R4 is (C1-C6)alkyl and R5 is cyano.
15. The compound of claim 1 which is
or a salt thereof.
16. The compound of claim 1 which is
or a salt thereof.
17. The compound of claim 1 which is
or a salt thereof.
18. A pharmaceutical composition comprising a compound or a pharmaceutically acceptable salt thereof, as described in claim 1, and a pharmaceutically acceptable diluent or carrier.
19. A therapeutic method for treating cancer in a mammal wherein the activity of Bcl-2 protein is implicated and antagonism of its action is desired comprising administering a compound of formula (I):
wherein:
R1 is (C1-C6)alkoxy or NRaRb;
R1 is cyano, (C1-C6)alkoxycarbonyl or \u2014C(O)NReRf;
each of R3, R6, R7 and R8 is independently hydrogen, halo, cyano, (C1-C6)alkyl, cycloalkyl, aryl, heteroaryl, aryl(C1-C6)alkyl or (C1-C6)alkoxycarbonyl;
Rc and Rd are independently hydrogen, (C1-C6)alkyl, (C1-C6)alkanoyl or arylcarbonyl; or
Rc and Rd taken together with the nitrogen to which they are attached form a pyrrolidino, piperidino, piperazino, or morpholino ring;
Re and Rf are independently hydrogen or (C1-C6)alkyl; or Rc and Rd taken together with the nitrogen to which they are attached form a pyrrolidino, piperidino, piperazino, or morpholino ring;
R4 and R5 are each hydrogen; or R4 is (C1-C6)alkyl and R5 is cyano;
Ra and Rb, are independently hydrogen or (C1-C6)alkyl; or Ra and Rb taken together with the nitrogen to which they are attached form a pyrrolidino, piperidino, piperazino, or morpholino ring;
wherein any aryl or heteroaryl of R3, R6, R7 or R8 is optionally substituted with one or more groups independently selected from halo, hydroxy, cyano, CF3, OCF3, OCHF2, (C1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkanoyl, aryloxy, NRgRh, benzyloxy, (C1-C6)alkoxycarbonyl, and (C1-C6)alkanoyloxy; and
each Rg and Rh is independently hydrogen or (C1-C6)alkyl; or Rg and Rh taken together with the nitrogen to which they are attached form a pyrrolidino, piperidino, piperazino, or morpholino ring;
or a pharmaceutically acceptable salt thereof to the mammal.
20. The compound of claim 2 which is
or a salt thereof.
21. The method of claim 19 wherein the cancer is acute lymphoblastic leukemia, an acute myelogenous leukemia, a chronic lyphocytic leukemia, breast cancer, colon cancer, liver cancer, lung cancer, pancreatic cancer, or prostate cancer.